Escalating costs of self-injury mortality in the 21st century United States: an interstate observational study

[1]  J. Pope,et al.  “It wasn’t here, and now it is. It’s everywhere": fentanyl’s rising presence in Oregon’s drug supply , 2022, Harm Reduction Journal.

[2]  S. Woolf,et al.  Changes in Life Expectancy Between 2019 and 2020 in the US and 21 Peer Countries , 2022, JAMA network open.

[3]  R. McHugh,et al.  Suicidal motivations among opioid overdose survivors: Replication and extension. , 2022, Drug and alcohol dependence.

[4]  T. Miller,et al.  Association of State Social and Environmental Factors With Rates of Self-injury Mortality and Suicide in the United States , 2022, JAMA network open.

[5]  Kevin N. Griffith,et al.  Medicaid expansion and drug overdose mortality during the COVID-19 pandemic in the United States , 2022, Drug and Alcohol Dependence.

[6]  C. Florence,et al.  State-Level Economic Costs of Fatal Injuries — United States, 2019 , 2021, MMWR. Morbidity and mortality weekly report.

[7]  C. Florence,et al.  Economic Cost of Injury — United States, 2019 , 2021, MMWR. Morbidity and mortality weekly report.

[8]  C. Florence,et al.  State-Level Economic Costs of Opioid Use Disorder and Fatal Opioid Overdose — United States, 2017 , 2021, MMWR. Morbidity and mortality weekly report.

[9]  T. Miller,et al.  Fatal self-injury in the United States, 1999–2018: Unmasking a national mental health crisis , 2021, EClinicalMedicine.

[10]  N. King,et al.  Declining Life Expectancy in the United States: Missing the Trees for the Forest. , 2020, Annual review of public health.

[11]  K. Nolte,et al.  Overcoming the limitations of ‘accident’ as a manner of death for drug overdose mortality: case for a death certificate checkbox , 2020, Injury Prevention.

[12]  A. Case,et al.  Deaths of Despair and the Future of Capitalism , 2020 .

[13]  Jungjin Kim,et al.  Suicidal motivations reported by opioid overdose survivors: A cross-sectional study of adults with opioid use disorder. , 2019, Drug and alcohol dependence.

[14]  K. Nolte,et al.  Unrecognised self-injury mortality (SIM) trends among racial/ethnic minorities and women in the USA , 2019, Injury Prevention.

[15]  D. Ciccarone.  The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis. , 2019, The International journal on drug policy.

[16]  T. Miller,et al.  Incidence and costs of injuries to children and adults in the United States , 2018, Injury Epidemiology.

[17]  E. Caine,et al.  Mortality in the United States from self-injury surpasses diabetes: a prevention imperative , 2018, Injury Prevention.

[18]  T. Miller,et al.  Method overtness, forensic autopsy, and the evidentiary suicide note: A multilevel National Violent Death Reporting System analysis , 2018, PloS one.

[19]  Haomiao Jia,et al.  Discerning suicide in drug intoxication deaths: Paucity and primacy of suicide notes and psychiatric history , 2018, PloS one.

[20]  P. Friedmann,et al.  Cost‐effectiveness of extended release naltrexone to prevent relapse among criminal justice‐involved individuals with a history of opioid use disorder , 2017, Addiction.

[21]  W. Viscusi,et al.  Anchoring biases in international estimates of the value of a statistical life , 2017, Journal of Risk and Uncertainty.

[22]  Gordon S. Smith,et al.  Self-injury Mortality in the United States in the Early 21st Century: A Comparison With Proximally Ranked Diseases. , 2016, JAMA psychiatry.

[23]  D. Shepard,et al.  Suicide and Suicidal Attempts in the United States: Costs and Policy Implications , 2015, Suicide & life-threatening behavior.

[24]  E. Caine,et al.  Self-injury Is the Eighth Leading Cause of Death in the United States: It Is Time to Pay Attention. , 2015, JAMA psychiatry.

[25]  N. Kapusta,et al.  Beyond suicide: action needed to improve self-injury mortality accounting. , 2014, JAMA psychiatry.

[26]  M. Eisemann,et al.  Drinking patterns, psychological distress and quality of life in a Norwegian general population-based sample , 2012, Quality of Life Research.

[27]  J. Luciano,et al.  Burden of chronic physical conditions and mental disorders in primary care , 2010, British Journal of Psychiatry.

[28]  S. Stack,et al.  Suicide-associated comorbidity among US males and females: a multiple cause-of-death analysis , 2007, Injury Prevention.

[29]  A. Harris,et al.  A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting , 2005, PharmacoEconomics.

[30]  Rosenfeld.  Impact of the brady act on homicide and suicide rates , 2000, Journal of the American Medical Association (JAMA).

[31]  T. Miller,et al.  Cost-outcome analysis in injury prevention and control: eighty-four recent estimates for the United States. , 2000, Medical care.

[32]  T. Miller.  The Plausible Range for the Value of Life––Red Herrings Among the Mackerel , 1990 .